New Zealand - English SELECT A COUNTRY


By investing in research and fostering a passionate environment devoted to innovation, we’re able to discover and create products that address patients’ most pressing health needs. Our portfolio of medicines, together with deep expertise across key areas of health and a robust pipeline of promising compounds, helps us make a difference for patients around the world.

Our Passion Helps Patients

Innovation is the cornerstone of AbbVie’s business as a global biopharmaceutical company. Our focus is on developing medicines that can offer strong clinical performance, provide measurable patient benefit and deliver economic value—particularly in areas where there is significant need—such as hepatitis C, neuroscience, immunology and oncology.

AbbVie’s approach to scientific innovation builds on an impressive track record of developing breakthrough science. Our scientists discovered and developed two of the first medications to treat HIV infection, helping to change the outlook for many patients impacted by this disease. Our work in immunology has benefited patients with rheumatoid arthritis, psoriasis, Crohn’s disease and other chronic, autoimmune conditions. We continue to advance scientific research across many disease areas.

Partnerships Play a Key Role

We also know that some of the most important medical breakthroughs often result from collaborative R&D agreements and from partnerships. To find potential new therapies for patients we look both inside and outside AbbVie for promising discoveries. We partner and collaborate with peer companies, universities, non-governmental organisations, as well as other relevant groups, to help find solutions for patients around the globe—because we recognise there are times when we can accomplish more together than alone.



Our core therapeutic areas include Hepatitis C (HCV), neuroscience, immunology and oncology.

Learn more »



We’re committed to advancing promising compounds and research to deliver essential therapies to patients.

View pipeline »



Our efforts are focused on areas where we believe we can have an even greater impact on the disease and how it is managed.

See our process »


The Abbvie Internet site that you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals and other products or uses of those products that are not approved in other countries or regions. If you are a resident of a country other than those to which the site is directed, please contact your local AbbVie affiliate to obtain the appropriate product information for your country of residence.

The Abbvie Internet site that you have requested may be in a language that differs from your country of origin.

The Abbvie Internet site that you have requested may not be optimised for your screen size.

Do you wish to continue to this Abbvie site?



The “Yes” link below will take you out of AbbVie family of websites.

Links which take you out of AbbVie worldwide web sites are not under the control of AbbVie, and AbbVie are not responsible for the contents of any such site or any further links from such site. AbbVie is providing these links to you only as a convenience and the inclusion of any link does not imply endorsement of the linked site by AbbVie.

The Internet site that you have requested may not be optimized to your screen size.

Do you wish to leave this site?